Data / Research funding / Rheumatoid Arthritis
Rheumatoid Arthritis: 304 NIH awards ($308.5M) to 106 organizations
304 NIH awards ($308.5M) in the NIH spending category Rheumatoid Arthritis, to 106 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
304 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Deciphering the Genomics of Gene Network Regulation of T Cell and Fibroblast States in Autoimmune Inflammation | NIH | National Human Genome Research Institute | 2021 to 2025 | $6,348,798 | August 20, 2021 | May 31, 2027 | LESLIE, CHRISTINA S | reporter.nih.gov |
| Phase II trial of GM-CSF/sargramostim in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2023 | $6,265,868 | February 1, 2021 | November 30, 2026 | POTTER, HUNTINGTON | reporter.nih.gov |
| Activation of Macrophages in Human Autoimmune Diseases | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $4,710,162 | March 1, 2000 | July 31, 2029 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease | NIH | National Institute on Aging | 2021 to 2022 | $4,709,163 | May 15, 2014 | August 31, 2023 | ZHANG, BIN | reporter.nih.gov |
| Chemical probes to decipher PAD biology | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $4,690,000 | June 1, 2016 | May 31, 2026 | THOMPSON, PAUL R | reporter.nih.gov |
| AIM-for-RA | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $4,499,382 | March 22, 2022 | December 31, 2026 | ANOLIK, JENNIFER HOWITT | reporter.nih.gov |
| Molecular basis of bioelectronic medicine | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $3,937,630 | May 1, 2016 | April 30, 2027 | TRACEY, KEVIN J | reporter.nih.gov |
| ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $3,900,002 | March 21, 2022 | December 31, 2026 | RITCHLIN, CHRISTOPHER TREVOR | reporter.nih.gov |
| RESOURCE BASED CENTER FOR MUSCULOSKELETAL BIOLOGY AND MEDICINE | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,860,791 | April 15, 2019 | June 30, 2029 | SILVA, MATTHEW J | reporter.nih.gov |
| Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial | NIH | National Eye Institute | 2021 to 2023 | $3,733,343 | May 1, 2019 | April 30, 2026 | ACHARYA, NISHA | reporter.nih.gov |
| CNS Pain Mechanisms in Early Rheumatoid Arthritis: Implications for the Acute to Chronic Pain Transition | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,704,355 | July 1, 2013 | April 30, 2027 | LEE, YVONNE CLAIRE | reporter.nih.gov |
| Single cell and spatial genomic analyses of specimens from patients with autoimmune diseases (Technology Core) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $3,700,281 | March 22, 2022 | December 31, 2026 | BRENNER, MICHAEL B. | reporter.nih.gov |
| Rheumatoid Arthritis-Related Autoantibodies, Articular Inflammation, and RA-Associated Interstitial Lung Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,692,582 | September 27, 2021 | June 30, 2027 | SPARKS, JEFFREY ANDREW | reporter.nih.gov |
| Unmodified and Post Translationally Modified CD4+ and CD8+ T cell Epitopes in Rheumatoid Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $3,237,408 | September 30, 2019 | September 29, 2023 | BENTON, RYAN | reporter.nih.gov |
| Investigating Mucosal Breaks in the Initiation and Progression of Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $3,091,101 | June 23, 2021 | April 30, 2026 | ROBINSON, WILLIAM H | reporter.nih.gov |
| Genetically-engineered stem cells for self-regulating arthritis therapy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,983,611 | April 1, 2022 | March 31, 2027 | GUILAK, FARSHID | reporter.nih.gov |
| Proteomic analysis of hydroxychloroquine prevention trials in T1D, RA and SLE | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $2,978,715 | August 18, 2023 | July 31, 2028 | BUCKNER, JANE HOYT | reporter.nih.gov |
| Role of Systemic Inflammation in Cognitive Decline: Rheumatoid Arthritis as a Prototype | NIH | National Institute on Aging | 2021 to 2024 | $2,977,796 | September 30, 2020 | May 31, 2026 | MYASOEDOVA, ELENA | reporter.nih.gov |
| A Novel IL-35 Expressing Probiotic Platform for Inducing Allergen Specific Tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,952,468 | May 1, 2020 | June 30, 2025 | FANGER, NEIL A | reporter.nih.gov |
| Rheumatoid Arthritis-associated Parenchymal Lung Disease: Clinical and Molecular Phenotypes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,937,551 | April 15, 2022 | March 31, 2027 | WASHKO, GEORGE R | reporter.nih.gov |
| A Novel Immunologically Enhanced Probiotic for Treating Rheumatoid Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $2,922,693 | February 23, 2021 | January 31, 2025 | FANGER, GARY | reporter.nih.gov |
| The role of cytotoxic T cells in rheumatoid arthritis pathogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,877,343 | September 1, 2021 | August 31, 2026 | ANDRADE, FELIPE | reporter.nih.gov |
| TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,853,080 | July 10, 2020 | June 30, 2026 | LUND, FRANCES E. | reporter.nih.gov |
| Molecular Determinants of Usual Interstitial Pneumonia (UIP) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,826,957 | April 1, 2022 | March 31, 2027 | SCHWARTZ, DAVID ALBERT | reporter.nih.gov |
| Rheumatoid Arthritis and the Risk of Cardiovascular Disease: Biomarkers Risk Prediction and Underlying Mechanisms | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,807,438 | June 15, 2022 | May 31, 2027 | SOLOMON, DANIEL HAL | reporter.nih.gov |
| Defining the influence of RA genetic susceptibility factors on T cell antigen specificity and functional state | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,784,187 | August 2, 2013 | March 31, 2026 | RAYCHAUDHURI, SOUMYA | reporter.nih.gov |
| Supramolecular biomaterials for tuning the inflammatory properties of the complement system | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,759,425 | June 1, 2022 | May 31, 2027 | COLLIER, JOEL H | reporter.nih.gov |
| Bridging clinical trial and real-world data via machine learning to advance rheumatoid arthritis treatment strategies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,718,736 | July 1, 2022 | June 30, 2027 | LIAO, KATHERINE PHOENIX | reporter.nih.gov |
| Macrophage Heterogeneity in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,660,867 | April 15, 2022 | February 28, 2027 | WINTER, DEBORAH RACHELLE | reporter.nih.gov |
| Continuation Application for the development of Integrated continuous and single-use (ICS) bioproduction platform (Phase IIB) | NIH | National Institute of General Medical Sciences | 2022 to 2023 | $2,495,306 | January 1, 2016 | March 31, 2024 | SHINKAZH, OLEG | reporter.nih.gov |
| A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis | NIH | National Institute on Aging | 2023 to 2025 | $2,434,680 | September 4, 2023 | June 30, 2027 | FANGER, GARY | reporter.nih.gov |
| Integrative analysis of high dimensional tissue molecular data to define key biological systems in autoimmune diseases (SBC) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,419,724 | March 18, 2022 | December 31, 2026 | RAYCHAUDHURI, SOUMYA | reporter.nih.gov |
| Post-Initiation control of transcription in inflammatory macrophages | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,363,024 | December 23, 2019 | November 30, 2025 | ROGATSKY, INEZ | reporter.nih.gov |
| Identification of key regulators in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,309,449 | August 1, 2014 | April 30, 2026 | WANG, WEI | reporter.nih.gov |
| Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $2,207,584 | September 1, 2018 | January 31, 2024 | BORDBAR, AARASH | reporter.nih.gov |
| Immunologic and Clinical Sequelae after COVID-19 in Patients with Systemic Autoimmune Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $2,205,056 | February 1, 2023 | January 31, 2028 | SPARKS, JEFFREY ANDREW | reporter.nih.gov |
| Targeting angiogenesis for fracture nonunion treatment under inflammatory diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $2,165,056 | September 9, 2020 | June 30, 2027 | SHEN, JIE | reporter.nih.gov |
| Pathogenesis of Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,153,155 | April 6, 2022 | February 28, 2027 | SCHULERT, GRANT SANFORD | reporter.nih.gov |
| Identifying a novel pathway that regulates RA immunometabolism | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $2,137,878 | July 8, 2022 | June 30, 2028 | SHAHRARA, SHIVA | reporter.nih.gov |
| Investigating monocyte dysfunction in Down Syndrome | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $2,109,849 | July 24, 2019 | December 31, 2024 | HAMERMAN, JESSICA A | reporter.nih.gov |
| Novel approaches to promote healing of bone loss in inflammatory arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $2,084,763 | March 14, 2022 | February 28, 2027 | SHIM, JAE-HYUCK | reporter.nih.gov |
| Engineered probiotic for the treatment of autoimmune diseases | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $2,050,291 | March 20, 2023 | February 29, 2028 | BEETON, CHRISTINE | reporter.nih.gov |
| Neutrophil Extracellular Traps in the Lung and Development of Rheumatoid Arthritis-Related Autoimmunity and Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $2,044,363 | February 7, 2020 | January 31, 2026 | DEMORUELLE, M. KRISTEN | reporter.nih.gov |
| Influence of bacterial tryptophan metabolism on inflammatory arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,982,751 | April 10, 2019 | July 31, 2029 | KUHN, KRISTINE A. | reporter.nih.gov |
| Employing the gut microbiome to accelerate effective initiation of rheumatoid arthritis therapy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,960,579 | September 1, 2019 | August 31, 2025 | SCHER, JOSE U. | reporter.nih.gov |
| Role of the CD47 Pathway in Rheumatoid Arthritis Pathogenesis and Treatment | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,960,562 | September 20, 2022 | July 31, 2027 | KORMAN, BENJAMIN DOUGLAS | reporter.nih.gov |
| Rapid quantification of nuclear citrullination in human neutrophils | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,952,315 | June 13, 2018 | January 31, 2023 | JOHNSTONE, ANDREA LYNN | reporter.nih.gov |
| Cytokine regulation of RA synoviocyte phenotype | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,930,588 | September 27, 1999 | May 31, 2027 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Sialylation of TLR2 Induces Osteoclast Fusion and Th 17 differentiation During Aging | NIH | National Institute on Aging | 2022 to 2025 | $1,926,073 | July 1, 2022 | March 31, 2027 | CAO, XU | reporter.nih.gov |
| B cell costimulatory signals in the pathogenesis of SLE | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,899,404 | August 1, 2019 | June 30, 2024 | JACKSON, SHAUN WILLIAM | reporter.nih.gov |
| Regulation of T helper cell functions by aryl hydrocarbon receptor | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,865,873 | May 18, 2021 | March 31, 2026 | RAO, DEEPAK ANGARA | reporter.nih.gov |
| Predicting uveitis onset in children with juvenile idiopathic arthritis | NIH | National Eye Institute | 2021 to 2023 | $1,863,787 | September 30, 2019 | June 30, 2025 | ANGELES-HAN, SHEILA THERESE | reporter.nih.gov |
| Defining the molecular and radiologic phenotype of progressive RA-ILD | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,845,758 | August 1, 2023 | May 31, 2028 | LEE, JOYCE SUJIN | reporter.nih.gov |
| Defining the Pathogenic Contribution of High Genotypic MIF Expression | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,816,705 | June 1, 2021 | April 30, 2026 | BUCALA, RICHARD J | reporter.nih.gov |
| Mechanistic Pharmacokinetics and Pharmacodynamics | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,792,910 | May 1, 2019 | April 30, 2025 | JUSKO, WILLIAM J. | reporter.nih.gov |
| Intra-Articular Drug Delivery Modulating Immune Cells in Inflammatory Joint Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,782,728 | February 1, 2023 | December 31, 2028 | ZHANG, LIANGFANG | reporter.nih.gov |
| Macrophages in human autoimmune tissue pathology | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,780,000 | May 4, 2020 | April 30, 2026 | DONLIN, LAURA T. | reporter.nih.gov |
| Role of PTPRS in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,765,973 | September 1, 2014 | March 31, 2027 | BOTTINI, NUNZIO | reporter.nih.gov |
| Synovial Macrophage Transcriptional Signatures for Predicting Therapeutic Efficacy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,724,874 | September 18, 2019 | July 31, 2025 | PERLMAN, HARRIS R | reporter.nih.gov |
| Preclinical Development of the TAK1 Inhibitor HS-276 for the Treatment of Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,709,883 | September 22, 2021 | August 31, 2024 | SCARNEO, SCOTT | reporter.nih.gov |
| Immune Checkpoint Inhibition and humoral immune response in systemic autoimmunity | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,697,982 | August 15, 2021 | February 28, 2027 | ZENG, HU | reporter.nih.gov |
| ProGel Technology for Better Management of Osteoarthritis Pain | NIH | National Institute on Drug Abuse | 2021 to 2022 | $1,680,880 | May 1, 2020 | December 31, 2023 | GOLDRING, STEVEN | reporter.nih.gov |
| Effectiveness of the HPV Vaccine in Immunocompromised Populations | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,654,519 | July 9, 2024 | May 31, 2029 | SILVERBERG, MICHAEL J | reporter.nih.gov |
| Elucidating the Mechanisms of Arthritic Flare and Developing Treatments | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,629,617 | August 15, 2009 | July 31, 2027 | SCHWARZ, EDWARD M. | reporter.nih.gov |
| Understanding A Molecular Cascade That Drives Neutrophil Mediated Pathology In Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,618,172 | February 9, 2023 | January 31, 2028 | ARANDJELOVIC, SANJA | reporter.nih.gov |
| DYNAMICS AND TUNING OF THE MHC II PRESENTED PEPTIDOME | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,603,685 | September 19, 2018 | August 31, 2025 | SANTAMBROGIO, LAURA | reporter.nih.gov |
| Gene-environment interaction pathways in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,581,271 | April 9, 2019 | February 28, 2025 | HOLOSHITZ, JOSEPH | reporter.nih.gov |
| Population-Based Outcomes Research for Rheumatoid Arthritis: Rural Health Disparities | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,574,497 | September 24, 2024 | July 31, 2029 | CROWSON, CYNTHIA S | reporter.nih.gov |
| Cytokine Balance in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,542,904 | September 10, 2004 | January 31, 2027 | IVASHKIV, LIONEL B | reporter.nih.gov |
| Role of protein citrullination in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,526,019 | February 1, 2020 | December 31, 2024 | MUSTELIN, TOMAS M | reporter.nih.gov |
| Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $1,499,167 | February 10, 2023 | January 31, 2028 | WANG, RUONING | reporter.nih.gov |
| Trained innate immunity and periodontitis-associated comorbidities | NIH | National Institute of Dental & Craniofacial Research | 2022 to 2025 | $1,487,525 | February 1, 2022 | January 31, 2027 | HAJISHENGALLIS, GEORGIOS | reporter.nih.gov |
| Profiling the human gut microbiome for potential analgesic bacterial therapies | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $1,446,416 | September 24, 2021 | May 31, 2023 | STRANDWITZ, PHILIP PETER | reporter.nih.gov |
| Complement in the Pathogenesis of Autoimmune Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,418,939 | September 10, 2004 | November 30, 2025 | HOLERS, VERNON MICHAEL | reporter.nih.gov |
| Expanded fibroblast subset drives pathology in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,413,588 | February 1, 2015 | August 31, 2026 | BRENNER, MICHAEL B. | reporter.nih.gov |
| Bridging the gap between GWAS and mechanism in arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,412,097 | December 1, 2018 | March 31, 2030 | NIGROVIC, PETER A | reporter.nih.gov |
| Molecular mechanisms of TAK1 regulation in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $1,407,925 | August 12, 2025 | July 31, 2028 | AHMED, SALAH-UDDIN | reporter.nih.gov |
| Neuroimaging Measures of Psychosocial Stress as Predictors of Articular and Arterial Inflammation, Cardiometabolic Disease, and Treatment Response in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,396,744 | September 27, 2021 | August 31, 2027 | BATHON, JOAN MARIE | reporter.nih.gov |
| Inflammation and Cardiovascular Disease in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,381,165 | May 1, 2004 | May 31, 2024 | BATHON, JOAN MARIE | reporter.nih.gov |
| Role of T-bet B cells in rheumatoid arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,373,874 | December 12, 2023 | October 31, 2028 | ANOLIK, JENNIFER HOWITT | reporter.nih.gov |
| Characterizing the negative signaling in dendritic cells and macrophages to attenuate inflammation and bone destruction in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,290,781 | February 15, 2020 | December 31, 2025 | LI, YI-PING | reporter.nih.gov |
| Cellular Senescence Network: New Imaging Tools for Arthritis Imaging | NIH | National Cancer Institute | 2023 to 2024 | $1,289,471 | September 23, 2021 | August 31, 2025 | DALDRUP-LINK, HEIKE ELIZABETH | reporter.nih.gov |
| Epigenetic Mechanisms That Drive Genetic Risk in Juvenile Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $1,284,216 | September 26, 2022 | February 24, 2024 | JARVIS, JAMES N | reporter.nih.gov |
| Epigenetic Mechanisms That Drive Genetic Risk in Juvenile Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,278,332 | September 26, 2022 | August 31, 2027 | JARVIS, JAMES N | reporter.nih.gov |
| The roles and mechanisms of inflammation resolution in the development of Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $1,268,125 | September 1, 2023 | August 31, 2028 | NORRIS, JILL M | reporter.nih.gov |
| Beyond Heart Disease in Rheumatoid Arthritis: Multimorbidity | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,267,216 | September 1, 2000 | September 21, 2023 | CROWSON, CYNTHIA S | reporter.nih.gov |
| The Pregnancy Transcriptome in Rheumatoid Arthritis - Renewal | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $1,238,738 | September 20, 2017 | August 31, 2030 | JAWAHEER, DAMINI | reporter.nih.gov |
| Uncovering the role of Setbp1 in fibroblast-like synoviocytes during inflammatory arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $1,188,998 | September 6, 2017 | July 31, 2029 | BHATTARAM, PALLAVI | reporter.nih.gov |
| Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease | NIH | National Center for Advancing Translational Sciences | 2021 | $1,186,828 | August 1, 2017 | June 30, 2022 | TRUSKEY, GEORGE A | reporter.nih.gov |
| NEURAXIAL AAVS TARGETING DRG CHANNELS INVOLVED IN CHRONIC POST INFLAMMATORY PAIN | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,182,994 | January 1, 2024 | December 31, 2028 | YAKSH, TONY L. | reporter.nih.gov |
| Roles of the Src-Family Kinases LynA and LynB in Macrophage Inflammatory Signaling | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,175,786 | September 1, 2018 | August 31, 2025 | FREEDMAN, TANYA S. | reporter.nih.gov |
| Targeting hexokinase-2 in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,170,750 | August 15, 2018 | May 31, 2024 | GUMA, MONICA | reporter.nih.gov |
| Mitochondrial Malfunction in T Cell Aging and Tissue Inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,144,649 | March 1, 2024 | February 28, 2029 | WEYAND, CORNELIA M. | reporter.nih.gov |
| Deciphering Pathways Driving Inflammatory Fibroblast Effector Functions in RA | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,136,015 | August 1, 2019 | July 31, 2024 | BRENNER, MICHAEL B. | reporter.nih.gov |
| Pathogenesis of autoimmune valvular carditis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,129,857 | July 15, 2014 | September 30, 2024 | BINSTADT, BRYCE | reporter.nih.gov |
| Understanding the structural dynamics of TNF receptors | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,120,569 | June 1, 2019 | May 31, 2024 | SACHS, JONATHAN N | reporter.nih.gov |
| Microbiota Control Lung Th17 Cell Response and Plasticity Leading to Autoimmune Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,115,457 | August 1, 2020 | July 31, 2025 | WU, HSIN-JUNG JOYCE | reporter.nih.gov |
| Magnesium and Arthritis Pathogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,103,784 | January 15, 2019 | December 31, 2023 | GULKO, PERCIO S | reporter.nih.gov |
| Bacterial peptidylarginine deiminase, a link between gums and joint disease | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2023 | $1,093,593 | February 1, 2013 | March 31, 2025 | POTEMPA, JAN S | reporter.nih.gov |
| Cellular Senescence Network: New Imaging Tools for Arthritis Imaging | NIH | National Cancer Institute | 2021 to 2022 | $1,059,697 | September 23, 2021 | August 31, 2023 | DALDRUP-LINK, HEIKE ELIZABETH | reporter.nih.gov |
| INPP5E Signaling and Treatment in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $1,055,452 | July 18, 2024 | June 30, 2029 | YANG, SHUYING | reporter.nih.gov |
| Role of PTPN2 in rheumatoid arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $1,052,726 | June 1, 2019 | April 9, 2023 | BOTTINI, NUNZIO | reporter.nih.gov |
| The immunological mechanism of PGRNs anti-inflammatory effect - Renewal - 1 | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,052,436 | September 1, 2012 | June 30, 2024 | LIU, CHUANJU | reporter.nih.gov |
| 15-LOX-1 as a druggable target in the acute to chronic pain transition of rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $1,041,920 | July 1, 2019 | May 31, 2025 | GREGUS, ANN MARIE | reporter.nih.gov |
| Control of B cell differentiation by IFNg induced transcription factors | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,039,868 | February 14, 2014 | November 30, 2025 | LUND, FRANCES E. | reporter.nih.gov |
| CD8 T cell derived Granzyme K activates complement that drives synovial fibroblast inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $1,028,392 | September 22, 2023 | August 31, 2028 | BRENNER, MICHAEL B. | reporter.nih.gov |
| Newly Identified T Peripheral Helper (Tph) Cells in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $1,010,963 | September 13, 2018 | June 30, 2023 | BRENNER, MICHAEL B. | reporter.nih.gov |
| T peripheral regulatory cells as modulators of T cell-B cell interactions in arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $991,974 | December 15, 2023 | November 30, 2028 | HENDERSON, LAUREN A | reporter.nih.gov |
| Tfh cells: linking the gut microbiota to a gut-distal autoimmune disease | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $985,398 | August 1, 2013 | January 31, 2025 | WU, HSIN-JUNG JOYCE | reporter.nih.gov |
| Local immunometabolism modulating biomaterials for immunosuppressive applications | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $978,635 | May 14, 2021 | August 15, 2023 | ACHARYA, ABHINAV | reporter.nih.gov |
| Gene Regulation as a Foundation for Autoimmune Disease Prevention | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $963,738 | June 1, 2017 | May 31, 2023 | WEIRAUCH, MATTHEW TYSON | reporter.nih.gov |
| Obesity-Induced Inflammatory Mediators Predict Lack of Response in Patients with Rheumatoid Arthritis Starting Biological Therapies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $946,648 | September 1, 2024 | August 31, 2029 | GUMA, MONICA | reporter.nih.gov |
| Defining the Role of Thymic Tolerance in the Pathogenesis of the COPA syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $946,280 | January 16, 2018 | December 31, 2023 | SHUM, ANTHONY | reporter.nih.gov |
| DNA Repair and Mitochondrial Dysfunction in T Cell Aging | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2024 | $919,378 | December 20, 2013 | December 31, 2025 | WEYAND, CORNELIA M. | reporter.nih.gov |
| Engineering synthetic ligands with potent allosteric inhibition of tumornecrosis factor receptors | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $878,581 | September 15, 2019 | June 30, 2024 | HACKEL, BENJAMIN | reporter.nih.gov |
| T resident memory cells in arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $851,419 | July 1, 2019 | May 31, 2025 | NIGROVIC, PETER A | reporter.nih.gov |
| The Exposome in Rheumatoid Arthritis and Systemic Lupus Erythematosus: EXACT Network Planning | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $843,158 | August 18, 2025 | August 31, 2026 | NORRIS, JILL M | reporter.nih.gov |
| Negative Regulation of Osteoclastogenesis | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $831,820 | September 8, 2008 | March 31, 2024 | IVASHKIV, LIONEL B | reporter.nih.gov |
| MicroRNA-based therapy for rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $817,760 | July 12, 2018 | June 30, 2024 | AHMED, SALAH-UDDIN | reporter.nih.gov |
| Remote Exposome Monitoring for Autoimmune Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $795,574 | September 18, 2023 | August 31, 2026 | LIAO, WILSON | reporter.nih.gov |
| Type I interferon Impacts Treatment Response in Rheumatoid Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $790,560 | July 1, 2022 | June 30, 2027 | WAMPLER MUSKARDIN, THERESA | reporter.nih.gov |
| Temporal associations between systemic inflammation, cardiovascular risk profile and development of Alzheimer’s disease and related dementias in patients with rheumatoid arthritis | NIH | National Institute on Aging | 2022 to 2025 | $760,568 | August 1, 2022 | April 30, 2027 | MYASOEDOVA, ELENA | reporter.nih.gov |
| A novel regulating pathway in osteoclastogenesis and arthritic bone resorption | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $756,427 | April 1, 2018 | January 31, 2024 | PARK-MIN, KYUNG-HYUN | reporter.nih.gov |
| Localization of Antibody Drugs to Arthritic Joints via Collagen Hybridization | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $756,245 | August 22, 2024 | July 31, 2029 | YU, MICHAEL S | reporter.nih.gov |
| Defining stress REsilience And Mindfulness Effects in Rheumatoid Arthritis (DREAMER) | NIH | National Center for Complementary & Integrative Health | 2022 to 2025 | $750,600 | January 1, 2022 | December 31, 2026 | PATTERSON, SARAH LYNN | reporter.nih.gov |
| Elucidating the neuroimmune mechanisms underlying pain and inflammation in autoimmune arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $742,426 | September 20, 2023 | June 30, 2028 | JAIN, AAKANKSHA | reporter.nih.gov |
| T cell expression of inflammatory chemokine receptors | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $735,372 | May 15, 2025 | February 28, 2030 | RAO, DEEPAK ANGARA | reporter.nih.gov |
| Development of resident memory T cells in the synovium | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $693,360 | April 4, 2022 | March 31, 2027 | CHANG, MARGARET | reporter.nih.gov |
| Joint-location specific pathogenic pathways in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $691,724 | July 1, 2018 | April 30, 2024 | FIRESTEIN, GARY S | reporter.nih.gov |
| An integrated nano- and micro-indentation system for musculoskeletal tissue and biomaterials | NIH | Office of the Director, National Institutes of Health | 2023 | $691,040 | April 1, 2023 | March 31, 2025 | LIU, XIAOWEI SHERRY | reporter.nih.gov |
| Mechanisms of inflammatory osteoblastogenesis and bone formation | NIH | National Institute on Aging | 2025 | $688,634 | December 1, 2024 | November 30, 2029 | ZHAO, BAOHONG | reporter.nih.gov |
| Particulate-based in vivo modulation for immunotherapy of Rheumatoid Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $675,002 | July 24, 2019 | June 30, 2025 | LEWIS, JAMAL S | reporter.nih.gov |
| Effects of biologic and targeted therapies for rheumatoid arthritis on cancer outcomes | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $674,665 | July 23, 2021 | June 30, 2025 | SUAREZ-ALMAZOR, MARIA E | reporter.nih.gov |
| Effects of health policy on the health of people with systemic autoimmune and rheumatic diseases | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $673,538 | May 25, 2025 | February 28, 2030 | TALABI, MEHRET BIRRU | reporter.nih.gov |
| Local immunometabolism modulating biomaterials for immunosuppressive applications | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $670,816 | May 14, 2021 | September 30, 2026 | ACHARYA, ABHINAV | reporter.nih.gov |
| Facilitating Endogenous Bone Repair in Arthritis with Targeted IL-27 Sonodelivery | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $663,541 | February 16, 2018 | January 31, 2025 | FIGUEIREDO, MARXA L | reporter.nih.gov |
| Optimal Dosing for Biologic Agents in Obese Patients with Rheumatoid and Juvenile Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $663,499 | August 26, 2020 | July 31, 2025 | BALEVIC, STEPHEN JOSEPH | reporter.nih.gov |
| Helping Adults with RA PREVAIL: Developing a model to Preserve Valued Activities In Life | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2025 | $663,123 | July 1, 2021 | September 30, 2026 | THOMA, LOUISE M. | reporter.nih.gov |
| Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $661,334 | July 1, 2022 | June 30, 2027 | SINGH, NAMRATA | reporter.nih.gov |
| Myeloid KLF2 regulation mechanisms in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $659,736 | April 1, 2016 | March 31, 2024 | DAS, HIRANMOY | reporter.nih.gov |
| Rheumatoid Arthritis and Autism Spectrum Disorder | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $656,244 | September 1, 2019 | June 30, 2024 | SANDIN, SVEN | reporter.nih.gov |
| Evaluating Clinical and Immunological Consequences of SARS-CoV-2 Vaccination in Rheumatic Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $655,352 | December 1, 2021 | November 30, 2025 | DOMSIC, ROBYN THERESE | reporter.nih.gov |
| Mechanisms of T Cell IFNy and IL-17 Production in Juvenile Idiopathic Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2025 | $655,344 | August 24, 2022 | July 31, 2027 | PATRICK, ANNA ELIZABETH | reporter.nih.gov |
| Inflammation-mediated platelet hyperreactivity and thrombosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $641,578 | March 5, 2021 | July 31, 2023 | DAVIZON-CASTILLO, PAVEL | reporter.nih.gov |
| Prevention Center U01: Early Targets for Antigen-Specific Tolerance Induction in Preclinical Rheumatoid Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $634,627 | July 5, 2012 | June 30, 2022 | HOLERS, VERNON MICHAEL | reporter.nih.gov |
| Pathogenic fibroblast differentiation in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $630,141 | August 1, 2020 | July 31, 2025 | WEI, KEVIN S | reporter.nih.gov |
| The Impact of Social Rejection: Investigating Pain-related Stigma in Adolescents with Chronic Widespread Musculoskeletal Pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $608,443 | February 1, 2020 | January 31, 2026 | WAKEFIELD, EMILY O | reporter.nih.gov |
| Silencing autoantibody secretion for SLE therapy | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $599,638 | May 8, 2023 | April 30, 2026 | MENDELSOHN, ANDREW R | reporter.nih.gov |
| Sleep Disturbance in Rheumatoid Arthritis: Phenotypes, Causes, and Impact | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $594,671 | July 1, 2017 | June 30, 2023 | KATZ, PATRICIA P | reporter.nih.gov |
| Acute Inhibition of TAK1 as a Means to Control COVID-19 Pulmonary Hyperinflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $593,995 | August 1, 2021 | May 31, 2024 | SCARNEO, SCOTT | reporter.nih.gov |
| Understanding disease modifying antirheumatic drug use in older adults with late-onset rheumatoid arthritis | NIH | National Institute on Aging | 2023 to 2025 | $583,200 | September 20, 2023 | June 30, 2028 | LEE, JIHA | reporter.nih.gov |
| 2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2024 | $575,999 | April 15, 2022 | March 31, 2026 | ORMSETH, MICHELLE JANE | reporter.nih.gov |
| Mentored Patient-Oriented Research of Novel Mechanisms Linking Pain, Sleep-Wake Patterns, and Autonomic Activity in Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $575,433 | February 24, 2023 | January 31, 2028 | LEE, YVONNE CLAIRE | reporter.nih.gov |
| Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $566,969 | September 28, 2015 | November 30, 2023 | SOLOMON, DANIEL HAL | reporter.nih.gov |
| Salt, Blood Pressure, and Inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 | $561,784 | January 1, 2018 | June 30, 2024 | STEIN, CHARLES M. | reporter.nih.gov |
| Role of PTPN2 in rheumatoid arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2023 | $556,419 | June 1, 2019 | May 31, 2026 | BOTTINI, NUNZIO | reporter.nih.gov |
| Task Order: Colorectal Cancer Prevention by a Novel EPA Analogue TP-252 and Naproxen in FAP and lynch syndrome models | NIH | National Cancer Institute | 2021 | $554,176 | September 15, 2019 | February 14, 2022 | KENNEDY, GREGORY | reporter.nih.gov |
| Development of Gold Nanocarriers for the Treatment ofRheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $551,178 | September 1, 2025 | July 31, 2028 | VASQUEZ, YOLANDA | reporter.nih.gov |
| Inflammatory Pathways in BPH/LUTS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $545,830 | September 15, 2018 | June 30, 2023 | HAYWARD, SIMON W | reporter.nih.gov |
| Defining the cellular and molecular mechanism of IDO2 function driving autoimmune vs.protective immune responses | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $529,682 | January 8, 2025 | December 31, 2029 | MANDIK-NAYAK, LAURA | reporter.nih.gov |
| A Notch-mediated fibrogenic program drives treatment failure in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $529,616 | June 1, 2025 | May 31, 2030 | WEI, KEVIN S | reporter.nih.gov |
| Developing a tool to support shared decision making in JIA between adolescents, parents, and providers | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $527,796 | September 15, 2023 | August 31, 2028 | MANNION, MELISSA | reporter.nih.gov |
| Endogenous retroviruses in autoimmunity: T cell repertoire, tolerance, and disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $527,760 | July 1, 2025 | April 30, 2030 | ASHOURI, JUDITH | reporter.nih.gov |
| Antifibrotic effects of Syndecan-2 and CD148 in Rheumatoid Arthritis Interstitial Lung Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $523,800 | May 1, 2020 | April 30, 2025 | TSOYI, KONSTANTIN | reporter.nih.gov |
| Validation of a Novel Ultrasound Score to Improve the Assessment of Joint Inflammation in Children with Juvenile Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $510,300 | August 1, 2023 | July 31, 2028 | VEGA FERNANDEZ, PATRICIA | reporter.nih.gov |
| A novel model of severe inflammatory arthritis induced by pulmonary silica exposure | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $506,000 | August 20, 2024 | July 31, 2026 | POLLARD, KENNETH MICHAEL | reporter.nih.gov |
| Domain adaptation approaches to unify established and emerging sequencing technologies | NIH | National Human Genome Research Institute | 2024 to 2025 | $497,998 | May 15, 2023 | July 31, 2027 | DAVIDSON, NATALIE ROSE | reporter.nih.gov |
| Adipose Inflammation in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $483,599 | September 15, 2016 | August 31, 2024 | BATHON, JOAN MARIE | reporter.nih.gov |
| Tfh cells: linking the gut microbiota to a gut-distal autoimmune disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $480,186 | August 1, 2013 | October 31, 2021 | WU, HSIN-JUNG JOYCE | reporter.nih.gov |
| Dietary Quality, Body Adiposity, and Risk of Rheumatoid Arthritis in Women | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $480,060 | May 1, 2018 | November 30, 2023 | SOLOMON, DANIEL HAL | reporter.nih.gov |
| Decoding synovial CD4+ T cell antigen specificities in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $472,870 | May 1, 2023 | April 30, 2027 | KOHLGRUBER, AYANO CHRISTINE | reporter.nih.gov |
| Antibiotics, Juvenile Idiopathic Arthritis, and Antirheumatic Treatment Response | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $466,279 | August 15, 2019 | June 30, 2025 | HORTON, DANIEL BENJAMIN | reporter.nih.gov |
| Allograft inflammatory factor-1 and immune tolerance | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $462,000 | June 10, 2022 | August 31, 2024 | SIBINGA, NICHOLAS E | reporter.nih.gov |
| Synoviocyte endothelial cell cross talk in rheumatoid arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $459,250 | June 20, 2025 | May 31, 2027 | BOTTINI, NUNZIO | reporter.nih.gov |
| Antibiotics, Juvenile Idiopathic Arthritis, and Antirheumatic Treatment Response | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $457,719 | August 15, 2019 | June 30, 2022 | HORTON, DANIEL BENJAMIN | reporter.nih.gov |
| Identifying Pharmacogenomic Predictors of Methotrexate Response and Metabolite Biotransformation in JIA | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $449,789 | September 1, 2017 | May 31, 2023 | THOMPSON, SUSAN D | reporter.nih.gov |
| The impact of the gut microbiome on rheumatoid arthritis treatment | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $448,856 | August 1, 2018 | February 29, 2024 | NAYAK, RENUKA RAJENDRA | reporter.nih.gov |
| Neuroimaging Measures of Psychosocial Stress as Predictors of Articular and Arterial Inflammation and Treatment Response in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $447,731 | September 1, 2025 | August 31, 2027 | GILES, JON T | reporter.nih.gov |
| Studying exceptional treatment non-responders and genetics to predict treatment response in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $444,383 | July 1, 2021 | June 30, 2024 | LIAO, KATHERINE PHOENIX | reporter.nih.gov |
| The Role of Efferocytosis in Inflammatory Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $444,125 | February 14, 2023 | January 31, 2025 | ARANDJELOVIC, SANJA | reporter.nih.gov |
| How immunodominant Fc peptide epitopes expand natural regulatory T cells and downregulate inflammation | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $436,964 | January 23, 2019 | June 30, 2022 | FRANCO, ALESSANDRA I | reporter.nih.gov |
| Architecture and interactions of Granzyme K+ CD8 T cells in inflamed synovium in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $435,888 | August 31, 2023 | August 31, 2027 | JONSSON, ANNA HELENA | reporter.nih.gov |
| Characterization of OGFRL1 Knockout Mice | NIH | National Institute of Dental & Craniofacial Research | 2021 to 2022 | $435,875 | March 1, 2021 | February 29, 2024 | UEKI, YASUYOSHI | reporter.nih.gov |
| Mining minority enriched AllofUs data for innovative ethnic specific risk prediction modeling | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2024 | $435,723 | September 25, 2023 | May 31, 2025 | ZHANG, RUI | reporter.nih.gov |
| Role of PTPRS in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $433,676 | September 1, 2014 | March 31, 2022 | BOTTINI, NUNZIO | reporter.nih.gov |
| Autoantibody modulation of cartilage turnover in rheumatoid arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $429,189 | April 9, 2021 | March 31, 2025 | FIELDS, GREGG B | reporter.nih.gov |
| HERV-K immunity, a trigger of citrullination in rheumatoid arthritis? | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $425,189 | May 10, 2021 | April 30, 2023 | MUSTELIN, TOMAS M | reporter.nih.gov |
| Weight loss and exercise to improve rheumatoid arthritis cardiovascular risk | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $422,171 | June 15, 2020 | May 31, 2023 | HUFFMAN, KIM M. | reporter.nih.gov |
| CD4+ T-cell Repertoires of the Lung in Rheumatoid Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $418,735 | September 22, 2021 | August 31, 2024 | DAI, SHAODONG | reporter.nih.gov |
| Inflammatory Arthritis: Mechanistic Insights into Initiation and Progression | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $418,360 | July 1, 2017 | May 31, 2022 | POPE, RICHARD M. | reporter.nih.gov |
| Development of a Synovium-on-a-Chip Microphysiological System to Interrogate Pathobiology and Enhance Precision Medicine in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $415,159 | March 1, 2024 | February 28, 2026 | CHEN, WEIQIANG | reporter.nih.gov |
| Regulation of Inflammation by IL1RN polymorphisms | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $408,326 | March 1, 2021 | February 29, 2024 | ABRAMSON, STEVEN B | reporter.nih.gov |
| The role of high endothelial venules in sex dimorphism in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $407,719 | September 15, 2023 | August 31, 2025 | SAWADA, JUNKO | reporter.nih.gov |
| Video Disease Activity Index: A novel video measure to monitor rheumatoid arthritis in telehealth | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $407,346 | August 20, 2024 | June 30, 2027 | HOWE, ROBERT D | reporter.nih.gov |
| Advancing precision pain medicines to the clinic | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $400,000 | September 22, 2023 | August 31, 2025 | MORENO, ANA MARIA | reporter.nih.gov |
| Peptidylarginine deiminase type 6 in rheumatoid arthritis pathogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $396,275 | September 23, 2021 | August 31, 2024 | ANDRADE, FELIPE | reporter.nih.gov |
| Causes and Roles of Hypercitrullination in Preclinical Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $395,133 | September 12, 2017 | July 31, 2023 | HO, I-CHENG | reporter.nih.gov |
| Prevention of arthritis-induced bone erosion by inhibiting osteoclast differentiation by the haloanilide, N-Methyl Dichloropropionaniline | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $394,939 | September 25, 2019 | August 31, 2024 | BARNETT, JOHN B | reporter.nih.gov |
| POP2 as a novel therapeutic in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $394,460 | September 23, 2022 | August 31, 2025 | HARTON, JONATHAN A | reporter.nih.gov |
| T resident memory cells in arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $393,991 | July 1, 2019 | August 31, 2021 | NIGROVIC, PETER A | reporter.nih.gov |
| Bridging the gap between GWAS and mechanism in JIA | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $393,800 | December 1, 2018 | June 30, 2021 | NIGROVIC, PETER A | reporter.nih.gov |
| Microfluidics-enabled directed affinity reagent engineering for fast, sensitive diagnostics | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2023 | $393,606 | August 15, 2022 | December 31, 2024 | SIKES, HADLEY D | reporter.nih.gov |
| Particulate-based in vivo modulation for immunotherapy of Rheumatoid Arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $392,500 | July 24, 2019 | June 30, 2022 | LEWIS, JAMAL S | reporter.nih.gov |
| Investigating immunophenotypic and transcriptional heterogeneity as biomarkers of pain centralization in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $387,200 | February 15, 2022 | January 31, 2025 | LEE, YVONNE CLAIRE | reporter.nih.gov |
| Ultrasensitive Doppler Ultrasound for Evaluation of Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $384,780 | July 10, 2022 | June 30, 2025 | CHEN, SHIGAO | reporter.nih.gov |
| SLAMF7 Regulates Synovial Macrophages in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $383,757 | September 26, 2019 | November 1, 2023 | SIMMONS, DAIMON P. | reporter.nih.gov |
| Determining the Pathogenic Roles of Granzyme K+ CD8 T Cells Unexpectedly Expanded in Rheumatoid Arthritis Synovium and Other Diseased Tissues | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $382,537 | August 1, 2025 | July 31, 2030 | JONSSON, ANNA HELENA | reporter.nih.gov |
| Immunomodulatory Biomaterials via Peptide and Protein Self-Assembly | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 | $381,129 | July 1, 2009 | May 31, 2023 | COLLIER, JOEL H | reporter.nih.gov |
| Role of synovial lining fibroblasts in inflammatory arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 to 2023 | $378,730 | April 1, 2022 | March 31, 2025 | BHATTARAM, PALLAVI | reporter.nih.gov |
| Endothelial Cell-Intrinsic Non-Canonical NF-kB in Chronic inflammation | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $377,932 | July 1, 2017 | April 30, 2022 | MAY, MICHAEL J | reporter.nih.gov |
| Natural history and validation of surrogate biomarkers and patient-reported outcomes for SJIA-LD | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $376,894 | August 15, 2024 | June 30, 2028 | SCHULERT, GRANT SANFORD | reporter.nih.gov |
| Investigating how platelet-derived growth factor receptors direct synovialfibroblast-mediated pathology in inflammatory arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $376,651 | September 10, 2020 | August 31, 2023 | LOOD, JAN CHRISTIAN | reporter.nih.gov |
| Synthetic Chronogenetic Gene Circuits for Circadian Cell Therapies | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $376,310 | September 20, 2023 | September 19, 2025 | GUILAK, FARSHID | reporter.nih.gov |
| Mechanisms of inflammatory bone remodeling | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $375,584 | April 1, 2016 | January 31, 2023 | ZHAO, BAOHONG | reporter.nih.gov |
| Longitudinal characterization of the role of the mucosal virome and microbiome in juvenile idiopathic arthritis flares | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $375,100 | September 20, 2024 | August 31, 2026 | CORRELL, COLLEEN KELLY MARIE | reporter.nih.gov |
| Structural-functional studies of gingipain biogenesis and localization | NIH | National Institute of Dental & Craniofacial Research | 2025 | $358,823 | September 11, 2025 | September 10, 2027 | FLETCHER, HANSEL M. | reporter.nih.gov |
| Elucidating Social Determinants and Mental Health Needs to Achieve Equity in Rheumatic Disease Care | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $358,000 | September 18, 2023 | August 31, 2025 | COSTENBADER, KAREN H | reporter.nih.gov |
| Signaling and repertoire differences in arthritogenic T cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $354,996 | August 1, 2018 | July 31, 2023 | ASHOURI, JUDITH | reporter.nih.gov |
| Activation of Synovial Lining Fibroblasts in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $351,920 | April 1, 2024 | March 31, 2029 | SMITH, MELANIE HENNEBRY | reporter.nih.gov |
| A novel mechanism of rheumatoid arthritis-associated pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $349,442 | August 6, 2017 | June 30, 2023 | QU, LINTAO | reporter.nih.gov |
| Risk and impact of infection resulting from treatment with chronic glucocorticoids in patients with rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $349,272 | August 1, 2018 | June 30, 2023 | GEORGE, MICHAEL D. | reporter.nih.gov |
| Sputum Tph cells and CD14+CD16+ monocytes in the development of RA | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $343,200 | January 1, 2024 | December 31, 2025 | DEMORUELLE, M. KRISTEN | reporter.nih.gov |
| Optimization of hyperlipidemia management among patients with rheumatoid arthritis: A patient-centered intervention development | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $342,360 | June 8, 2022 | November 30, 2022 | NAVARRO-MILLÁN, IRIS Y | reporter.nih.gov |
| Oligoclonal T Cell Expansion and Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $336,530 | September 30, 1993 | January 31, 2025 | WEYAND, CORNELIA M. | reporter.nih.gov |
| The Reprogramming of Regulatory T cells to a Th17 Phenotype in Systemic Juvenile Idiopathic Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $335,970 | April 1, 2018 | September 30, 2023 | HENDERSON, LAUREN A | reporter.nih.gov |
| Sex, Stress and Immunity in the Acute to Chronic Pain Transition | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $332,894 | December 15, 2016 | November 30, 2021 | YAKSH, TONY L. | reporter.nih.gov |
| Mentoring Patient-Oriented Pharmacoepidemiologic Research in Rheumatic Diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $332,700 | April 1, 2021 | August 31, 2022 | KIM, SEOYOUNG CATHERINE | reporter.nih.gov |
| TET2-driven Clonal Hematopoiesis Promotes Disease Progression in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2023 | $327,396 | August 12, 2019 | July 31, 2024 | MACLAUCHLAN, SUSAN C. | reporter.nih.gov |
| Inhibitory Receptors and Autoimmune Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $324,368 | May 13, 2016 | April 30, 2024 | YI, AE-KYUNG | reporter.nih.gov |
| Characterizing the mechanism by which endogenous negative regulators of osteoclasts control bone homeostasis under physiological and pathological conditions in mouse models | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $324,368 | April 1, 2017 | March 31, 2024 | CHEN, WEI | reporter.nih.gov |
| The Effect of Exercise on T Cell Aging in Rheumatoid Arthritis | NIH | National Institute on Aging | 2024 to 2025 | $321,284 | August 15, 2024 | April 30, 2029 | ANDONIAN, BRIAN JAMES | reporter.nih.gov |
| Deciphering Complement-Dependent Macrophage Phenotypes in Human Autoimmune Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $320,417 | August 15, 2025 | July 31, 2030 | ZHANG, FAN | reporter.nih.gov |
| Open Tools for Self-Tracking, Self Experimentation, and Patient-Provider Collaboration in Symptom Self-Management and Clinical Care | NIH | National Library of Medicine | 2021 | $318,377 | September 5, 2018 | May 31, 2024 | FOGARTY, JAMES A | reporter.nih.gov |
| Elucidating the neuroimmune mechanisms underlying pain and inflammation in autoimmune arthritis (Admin Supplement) | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $316,116 | January 1, 2025 | June 30, 2025 | JAIN, AAKANKSHA | reporter.nih.gov |
| Bispecific biologic for rheumatoid arthritis therapy | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $312,323 | July 15, 2025 | June 30, 2027 | STANFORD, STEPHANIE | reporter.nih.gov |
| HLA Gene Editing in the Treatment of Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $306,827 | September 15, 2025 | August 31, 2026 | FREED, BRIAN M | reporter.nih.gov |
| Intramuscular Administration of AAV Vectors Encoding soluble PD-L1 for Rheumatoid Arthritis Treatment | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $304,502 | September 19, 2025 | August 31, 2027 | SUN, JUNJIANG | reporter.nih.gov |
| Engineering a unique antibody for patients with RA | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $300,000 | April 16, 2020 | March 31, 2023 | MARUYAMA, TOSHIAKI | reporter.nih.gov |
| A novel role for Reelin therapeutics in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $300,000 | September 1, 2022 | August 31, 2023 | KOUNNAS, MARIA Z | reporter.nih.gov |
| Reformulating NT-Z001 and its delivery route to treat rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $297,327 | September 18, 2025 | August 31, 2026 | QI, YANMEI | reporter.nih.gov |
| Novel first-in-class Therapeutics for Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $295,924 | September 7, 2023 | August 31, 2025 | BASSAGANYA-RIERA, JOSEP | reporter.nih.gov |
| A Potent D-peptide Inhibitor of TNFα for Treatment of Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $295,894 | September 20, 2023 | August 31, 2025 | RISDON, GRANT H | reporter.nih.gov |
| Impact of rheumatoid arthritis on survival in older adults with cancer | NIH | National Institute on Aging | 2023 to 2024 | $288,628 | August 15, 2023 | April 30, 2026 | SINGH, NAMRATA | reporter.nih.gov |
| Role of the gut barrier in inflammatory arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 to 2025 | $287,898 | September 1, 2024 | August 31, 2029 | ZHAO, FANG | reporter.nih.gov |
| Modulation of Protein S-nitrosylation Signaling as a Potential Therapeutic Breakthrough in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $279,654 | September 20, 2023 | August 31, 2025 | BRADLEY, MATTHEWS OGDEN | reporter.nih.gov |
| Non-immunosuppressive rheumatoid arthritis DMARD | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $274,414 | September 21, 2023 | August 31, 2025 | STANFORD, STEPHANIE | reporter.nih.gov |
| DISPOSABLE DEVICE FOR RAPID POINT-OF-CARE DETECTION AND COMPARISON OF ANTIBODY RESPONSES AGAINST THERAPEUTIC PROTEINS IN RHEUMATOID ARTHRITIS PATIENTS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $258,953 | September 20, 2022 | August 31, 2025 | BARBOSA, MARIA D. F. S. | reporter.nih.gov |
| The role of GLUT3 in the genetics of autoimmunity and immunometabolism | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $255,420 | August 1, 2018 | July 31, 2023 | SIMPFENDORFER, KIM R | reporter.nih.gov |
| Development of ITCH-activating IRAK4 degraders as dual-targeting drug candidates for the treatment of rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $254,561 | September 1, 2022 | August 31, 2024 | SURESH, KUMAR | reporter.nih.gov |
| A Peptide-Based Polyplex Platform for Nucleotides Delivery to the Sites of Inflammation | NIH | National Center for Advancing Translational Sciences | 2021 | $254,092 | September 15, 2021 | September 14, 2023 | WICKLINE, SAMUEL A | reporter.nih.gov |
| Injectable Ice Slurry Cooling Technology for Treatment of Postoperative Pain | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $252,130 | September 27, 2022 | March 31, 2024 | SIDOTI, CHARLES | reporter.nih.gov |
| Novel Nontoxic Therapeutic Interventions for Autoimmune Inflammatory Disease | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $251,250 | May 1, 2014 | April 30, 2024 | ARANOW, CYNTHIA | reporter.nih.gov |
| Microbiota Control Lung Th17 Cell Response and Plasticity Leading to Autoimmune Lung Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $240,424 | August 1, 2020 | October 31, 2021 | WU, HSIN-JUNG JOYCE | reporter.nih.gov |
| Molecular control of CD4 T cell ability to help B cells | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $232,834 | March 1, 2018 | February 28, 2023 | RAO, DEEPAK ANGARA | reporter.nih.gov |
| Inflammation-mediated platelet hyperreactivity and thrombosis | NIH | National Heart, Lung, and Blood Institute | 2024 | $210,724 | March 5, 2021 | February 28, 2025 | DAVIZON-CASTILLO, PAVEL | reporter.nih.gov |
| Domain adaptation approaches to unify established and emerging sequencing technologies | NIH | National Human Genome Research Institute | 2023 to 2024 | $201,193 | May 15, 2023 | September 23, 2024 | DAVIDSON, NATALIE ROSE | reporter.nih.gov |
| Functional plasticity of Th17 in arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $197,448 | June 24, 2020 | May 31, 2023 | BOTTINI, NUNZIO | reporter.nih.gov |
| Computational methods using electronic health records and registry data to detect and predict clinical outcomes in rheumatic disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $197,001 | April 10, 2019 | March 4, 2022 | GIANFRANCESCO, MILENA ANNE | reporter.nih.gov |
| Applying a Targeted Machine Learning and Causal Inference Approach to Analyzing Long-Term Sequelae of COVID-19 Infection Through the National COVID Cohort Collaborative. | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $190,688 | September 4, 2024 | May 31, 2026 | BUTZIN-DOZIER, ZACHARY | reporter.nih.gov |
| Cellular mechanisms of macrophage activation syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $188,772 | June 17, 2025 | May 31, 2030 | CANNY, SUSAN PRISCILLA | reporter.nih.gov |
| Insights into the origin of ACPAs in RA | NIH | National Institute of Allergy and Infectious Diseases | 2025 | $187,938 | January 9, 2025 | December 31, 2026 | ANDRADE, FELIPE | reporter.nih.gov |
| Refining entry criteria and outcome measures for children with axial disease and spondyloarthritis: preparation for clinical trials | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $187,792 | August 12, 2019 | July 31, 2024 | WEISS, PAMELA FITCH | reporter.nih.gov |
| Building a Collaborative Research and TrainingPlatform for HIV and Rheumatic and Musculoskeletal Diseases in Uganda | NIH | Fogarty International Center | 2025 | $187,169 | July 21, 2025 | June 30, 2027 | KADDUMUKASA, MARK | reporter.nih.gov |
| Appraising the Fracture Risk Assessment Tool (FRAX) in persons with rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $177,120 | September 1, 2025 | August 31, 2030 | ELAM, RACHEL ELIZABETH | reporter.nih.gov |
| Building a Collaborative Research and Training Platform for HIV and Rheumatic and Musculoskeletal Diseases in Uganda | NIH | Fogarty International Center | 2024 | $174,753 | August 19, 2024 | June 30, 2026 | HSIEH, EVELYN | reporter.nih.gov |
| The Anti-Cyclic Citrullinated Protein Antibody Repertoire and Lung Involvement in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $174,645 | September 4, 2020 | August 31, 2024 | SOLOMON, JOSHUA | reporter.nih.gov |
| Architecture and interactions of Granzyme K+ CD8 T cells in inflamed synovium in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $173,880 | September 1, 2022 | June 2, 2023 | JONSSON, ANNA HELENA | reporter.nih.gov |
| Wnt signaling as a driver of pathogenic stromal inflammation in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $173,247 | February 1, 2024 | January 31, 2029 | MUELLER, ALISA ANNE | reporter.nih.gov |
| Inflammatory Responses, Fibrotic Mediators, and Comorbidity Burden as Determinants of Myocardial Dysfunction and Heart Failure in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $172,034 | August 15, 2025 | June 30, 2030 | JOHNSON, TATE | reporter.nih.gov |
| Using Chromatin Architecture to Develop of Therapeutic Pipeline for Juvenile Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $170,186 | August 21, 2020 | July 31, 2023 | JARVIS, JAMES N | reporter.nih.gov |
| DISSECTING THE SPATIAL HETEROGENEITY OF SYNOVIAL INFLAMMATION IN RHEUMATOID ARTHRITIS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $170,101 | January 1, 2025 | December 31, 2029 | RESHEF, YAKIR ABRAHAM | reporter.nih.gov |
| FAM26F function and role in macrophages | NIH | National Center for Advancing Translational Sciences | 2022 | $169,500 | August 1, 2022 | July 31, 2023 | FESKE, STEFAN | reporter.nih.gov |
| Pathogenic role of ILC2 in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $168,586 | September 24, 2020 | August 31, 2023 | FIRESTEIN, GARY S | reporter.nih.gov |
| Monocyte and macrophage polarization in systemic juvenile idiopathic arthritis and macrophage activation syndrome. | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $168,480 | August 7, 2017 | July 31, 2022 | SCHULERT, GRANT SANFORD | reporter.nih.gov |
| Stem cell therapy for fracture nonunion under inflammatory diseases | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $168,052 | August 1, 2020 | July 31, 2023 | SHEN, JIE | reporter.nih.gov |
| Total-Body PET/CT for assessing Rheumatoid Arthritis Disease Activity and Treatment Response | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $167,519 | August 1, 2019 | July 31, 2024 | CHAUDHARI, ABHIJIT J | reporter.nih.gov |
| Synovium Immunoprivilege and the Modulation of Resident Synovial Macrophage Functions in Lyme Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $167,076 | May 15, 2025 | April 30, 2030 | CYNDARI, KAREN I | reporter.nih.gov |
| A Novel Ultrasound Score to Improve the Assessment of Joint Inflammation in Children with Chronic Musculoskeletal Pain | NIH | National Center for Advancing Translational Sciences | 2025 | $162,000 | September 1, 2025 | August 31, 2027 | VEGA FERNANDEZ, PATRICIA | reporter.nih.gov |
| Accelerated Metabolic Aging in Rheumatoid Arthritis Immune cells and Skeletal Muscle: A Pilot Study | NIH | National Institute on Aging | 2021 | $161,000 | August 15, 2020 | May 31, 2024 | ANDONIAN, BRIAN JAMES | reporter.nih.gov |
| Microbial metabolites impacting the response to methotrexate in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2024 | $159,078 | April 1, 2023 | December 31, 2025 | NAYAK, RENUKA RAJENDRA | reporter.nih.gov |
| An integrative study of circulating leukocyte composition, epigenetic patterns, and functional consequences in knee osteoarthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $158,981 | August 1, 2020 | May 31, 2022 | JEFFRIES, MATLOCK | reporter.nih.gov |
| Evaluation of treatment patterns and prescription medication use among older adults with late-onset rheumatoid arthritis | NIH | National Institute on Aging | 2021 | $153,928 | September 15, 2020 | May 31, 2023 | LEE, JIHA | reporter.nih.gov |
| Population-Based Outcomes Research for Rheumatoid Arthritis: Rural Health Disparities | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $150,000 | September 1, 2000 | August 31, 2024 | CROWSON, CYNTHIA S | reporter.nih.gov |
| Fibroblast-mediated inflammatory resolution of rheumatoid arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $148,389 | January 1, 2023 | December 31, 2025 | ZOU, ANGELA ELIZABETH | reporter.nih.gov |
| Mentoring Patient-Oriented Research Leveraging Bioinformatics to Study CV Risk in Rheumatic Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $147,917 | January 1, 2025 | December 31, 2029 | LIAO, KATHERINE PHOENIX | reporter.nih.gov |
| Investigating the link between REV-ERB and HIF-1a in Th17 cell function | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $142,622 | July 11, 2023 | June 30, 2025 | GRIFFETT, KRISTINE | reporter.nih.gov |
| Trained immunity as a link between Inflammatory Arthritis and development of Cardiovascular Disease | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $139,895 | September 19, 2024 | August 31, 2026 | MACLAUCHLAN, SUSAN C. | reporter.nih.gov |
| Non-coding genetic risk variants modulating Tregs in arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $122,563 | August 18, 2025 | July 31, 2030 | KIM, TAEHYEUNG | reporter.nih.gov |
| Regulation and function of CCR2 on T cells in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 to 2025 | $115,952 | May 1, 2023 | April 30, 2026 | BRACERO, SABRINA ESMERALDA | reporter.nih.gov |
| The role of indole-induced immune dysregulation in collagen-inducedarthritis | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2025 | $111,528 | December 1, 2022 | November 30, 2025 | SEYMOUR, BRENDA J | reporter.nih.gov |
| Mechanisms enabling the oral-to-systemic absorption of a microbially delivered immunomodulatory peptide | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $102,756 | August 6, 2024 | August 5, 2027 | KADY, MOHAMED RYAN | reporter.nih.gov |
| Decoding synovial CD4+ T cell antigen specificities in Rheumatoid Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2023 | $93,960 | May 1, 2023 | April 30, 2024 | KOHLGRUBER, AYANO CHRISTINE | reporter.nih.gov |
| HLA at the Interface of Self and Other During Pregnancy | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $88,000 | April 14, 2021 | March 31, 2022 | NELSON, J. LEE | reporter.nih.gov |
| HLA at the Interface of Self and Other During Pregnancy | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $88,000 | April 14, 2021 | March 31, 2023 | NELSON, J. LEE | reporter.nih.gov |
| Nociplastic mechanisms in somatic and visceral pain | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2024 | $85,868 | September 1, 2023 | August 31, 2025 | WALLER, NOAH C. | reporter.nih.gov |
| Skeletal muscle in rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2022 | $83,119 | September 1, 2016 | August 31, 2023 | HANAOKA, BEATRIZ | reporter.nih.gov |
| Tools to evaluate POP2 as a regulator of arthritis | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $81,500 | March 1, 2020 | February 28, 2023 | HARTON, JONATHAN A | reporter.nih.gov |
| Engineered biomaterials modulating inflammatory T cells in rheumatic arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $78,823 | September 30, 2021 | September 29, 2023 | MCBRIDE, DAVID AMBROSE | reporter.nih.gov |
| Cadherin-11-cre deleter mouse | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $76,298 | September 24, 2021 | July 31, 2022 | BOTTINI, NUNZIO | reporter.nih.gov |
| Development of a Pediatric Rheumatology Common Data Element set (CDE) for Juvenile Idiopathic Arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2025 | $74,834 | August 1, 2025 | July 31, 2026 | NATTER, MARC DAVID | reporter.nih.gov |
| The Role of Checkpoint inhibitors in CIA | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2022 | $50,118 | July 1, 2020 | August 15, 2022 | WOOD, MEGAN KAY | reporter.nih.gov |
| Immunoregulatory biomaterials for modulating arthritis flares | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2024 | $41,566 | August 19, 2024 | August 18, 2026 | JOHNSON, WADE TRUMAN | reporter.nih.gov |
| Characterizing the negative signaling in dendritic cells and macrophages to attenuate inflammation and bone destruction in Rheumatoid arthritis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $22,869 | February 15, 2020 | April 6, 2021 | LI, YI-PING | reporter.nih.gov |
| Elucidating the Role of Sulfatase-2 in RA Pathogenesis | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 | $12,255 | August 16, 2021 | December 15, 2021 | SIEGEL, RUBY J. | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Brigham and Women's Hospital | Boston, MA | 33 | $36.8 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 18 | $22.5 million | 0 | $0 |
| Hospital for Special Surgery | New York, NY | 11 | $16.1 million | 0 | $0 |
| University of Rochester | Rochester, NY | 5 | $13.4 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 10 | $11.2 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 15 | $10.9 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 7 | $10.7 million | 0 | $0 |
| Washington University | Saint Louis, MO | 6 | $9.8 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 10 | $8.5 million | 0 | $0 |
| Benaroya Research Inst at Virginia Mason | Seattle, WA | 3 | $8.3 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 2 | $6.8 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 8 | $6.6 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 3 | $6.5 million | 0 | $0 |
| Sloan-Kettering Inst Can Research | New York, NY | 1 | $6.3 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 7 | $6.2 million | 0 | $0 |
| Duke University | Durham, NC | 7 | $5.9 million | 0 | $0 |
| University of Washington | Seattle, WA | 9 | $5.8 million | 0 | $0 |
| Stanford University | Stanford, CA | 3 | $5.4 million | 0 | $0 |
| Rise Therapeutics, LLC | Rockville, MD | 2 | $5.4 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 9 | $5.3 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 6 | $5.1 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 5 | $5 million | 0 | $0 |
| Feinstein Institute for Medical Research | Manhasset, NY | 3 | $4.4 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 5 | $4 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 4 | $3.6 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 3 | $3.3 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 3 | $3.2 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 4 | $3.2 million | 0 | $0 |
| Virtici, LLC | Seattle, WA | 1 | $3 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 3 | $2.7 million | 0 | $0 |
| Chromatan Corporation | Dedham, MA | 1 | $2.5 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 4 | $2.4 million | 0 | $0 |
| Eydis Bio, Inc. | Durham, NC | 2 | $2.3 million | 0 | $0 |
| Washington State University | Pullman, WA | 3 | $2.2 million | 0 | $0 |
| Sinopia Biosciences, Inc. | San Diego, CA | 1 | $2.2 million | 0 | $0 |
| Ohio State University | Columbus, OH | 3 | $2.2 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 1 | $2.1 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 2 | $2.1 million | 0 | $0 |
| Yale University | New Haven, CT | 2 | $2 million | 0 | $0 |
| Epicypher, Inc. | Research Triangle Park, NC | 1 | $2 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 2 | $1.9 million | 0 | $0 |
| Seattle Children's Hospital | Seattle, WA | 1 | $1.9 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 3 | $1.8 million | 0 | $0 |
| Ensign Pharmaceutical, INC | Omaha, NE | 1 | $1.7 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 1 | $1.7 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 2 | $1.6 million | 0 | $0 |
| Emory University | Atlanta, GA | 2 | $1.6 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 1 | $1.5 million | 0 | $0 |
| Holobiome, Inc. | Cambridge, MA | 1 | $1.4 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 2 | $1.3 million | 0 | $0 |
| University of Louisville | Louisville, KY | 1 | $1.1 million | 0 | $0 |
| Virginia Polytechnic Institute and State University | Blacksburg, VA | 1 | $1 million | 0 | $0 |
| Arizona State University | Scottsdale, AZ | 1 | $978,635 | 0 | $0 |
| University of Utah | Salt Lake City, UT | 1 | $756,245 | 0 | $0 |
| University of Arizona | Tucson, AZ | 2 | $720,610 | 0 | $0 |
| Navega Therapeutics, Inc. | San Diego, CA | 2 | $697,327 | 0 | $0 |
| University of Florida | Gainesville, FL | 1 | $675,002 | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 1 | $674,665 | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 1 | $670,816 | 0 | $0 |
| Purdue University | West Lafayette, IN | 1 | $663,541 | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 1 | $663,123 | 0 | $0 |
| Texas Tech University Health Scis Center | Lubbock, TX | 1 | $659,736 | 0 | $0 |
| Connecticut Children's Medical Center | Hartford, CT | 1 | $608,443 | 0 | $0 |
| Larix Bioscience, LLC | Sunnyvale, CA | 1 | $599,638 | 0 | $0 |
| Knoubis Bio, Inc. | San Diego, CA | 2 | $586,737 | 0 | $0 |
| University of California at Davis | Davis, CA | 2 | $560,019 | 0 | $0 |
| Oklahoma State University | Stillwater, OK | 1 | $551,178 | 0 | $0 |
| Endeavor Health Clinical Operations | Evanston, IL | 1 | $545,830 | 0 | $0 |
| Lankenau Institute for Medical Research | Wynnewood, PA | 1 | $529,682 | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 1 | $506,000 | 0 | $0 |
| Albany Medical College | Albany, NY | 2 | $475,960 | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 1 | $466,279 | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 1 | $462,000 | 0 | $0 |
| Rutgers University New Brunswick | New Brunswick, NJ | 1 | $457,719 | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 1 | $435,875 | 0 | $0 |
| Florida Atlantic University | Boca Raton, FL | 1 | $429,189 | 0 | $0 |
| New York University | New York, NY | 1 | $415,159 | 0 | $0 |
| Harvard University | Cambridge, MA | 1 | $407,346 | 0 | $0 |
| Exesalibero, Inc. | Morgantown, WV | 1 | $394,939 | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 1 | $393,606 | 0 | $0 |
| Loma Linda University | Loma Linda, CA | 1 | $358,823 | 0 | $0 |
| University of Tennessee Health Sci CTR | Memphis, TN | 1 | $324,368 | 0 | $0 |
| Rheumagen, Inc. | Denver, CO | 1 | $306,827 | 0 | $0 |
| Bedrock Therapeutics, Inc. | Chapel Hill, NC | 1 | $304,502 | 0 | $0 |
| Abwiz Bio, Inc. | San Diego, CA | 1 | $300,000 | 0 | $0 |
| Reelin Therapeutics, Inc. | San Diego, CA | 1 | $300,000 | 0 | $0 |
| Biotherapeutics, Inc. | Blacksburg, VA | 1 | $295,924 | 0 | $0 |
| D Biotherapeutics, LLC | Salt Lake City, UT | 1 | $295,894 | 0 | $0 |
| Gsno Therapeutics, Inc. | Shelton, WA | 1 | $279,654 | 0 | $0 |
| Harvard Medical School | Boston, MA | 2 | $264,341 | 0 | $0 |
| Conquerab, Inc. | Gainesville, FL | 1 | $258,953 | 0 | $0 |
| Progenra, Inc. | Malvern, PA | 1 | $254,561 | 0 | $0 |
| Trasir Therapeutics, Inc. | Temple Terrace, FL | 1 | $254,092 | 0 | $0 |
| Brixton Biosciences, Inc. | Cambridge, MA | 1 | $252,130 | 0 | $0 |
| Bloodworks | Seattle, WA | 1 | $210,724 | 0 | $0 |
| University of California-Berkeley | Berkeley, CA | 1 | $190,688 | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 1 | $187,792 | 0 | $0 |
| Makerere University College of Health Sciences | Kampala | 1 | $187,169 | 0 | $0 |
| Augusta University | Augusta, GA | 1 | $177,120 | 0 | $0 |
| National Jewish Health | Denver, CO | 1 | $174,645 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 118 | $53,012,890 | 0 | $0 |
| 2024 | 117 | $49,328,672 | 0 | $0 |
| 2023 | 141 | $66,701,179 | 0 | $0 |
| 2022 | 151 | $71,361,686 | 0 | $0 |
| 2021 | 152 | $68,097,078 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.